Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre <scp>UK</scp> experienceNicola Maciocia, Neil Rabin, Karthik Ramasamy et al.|British Journal of Haematology|2017Cited by 31
Outcome of Pomalidomide Therapy in Relapsed /Refractory Myeloma: A Uk Multi-Centre ExperienceNicola Maciocia, Neil Rabin, Faye Sharpley et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3